I compare ACR's preferred stocks, ACR.PR.C and ACR.PR.D, highlighting their dividend yields and potential returns, with a preference for dividend-focused investments. ACR.PR.C, a fixed-to-floating rate preferred stock, has provided a 48.1% total gain since my investment in October 2022. ACR.PR.D, a fixed-rate preferred stock, is expected to outperform ACR.PR.C in total return as the Federal Reserve lowers interest rates.
ACRES Commercial Realty Corp. is up substantially over the last 1-year as the mREIT moves to close its discount to book value. ACR's book value grew by 95 cents sequentially to $28.87 per share, with the commons currently trading hands at a 27% discount to book value. The floating rate Series C preferreds are a play for income, currently paying out a 10.4% yield on cost but trading 22 cents above their liquidation value per share.
Start Time: 10:00 January 1, 0000 10:18 AM ET ACRES Commercial Realty Corp. (NYSE:ACR ) Q4 2024 Earnings Conference Call March 06, 2025, 10:00 AM ET Company Participants Mark Fogel - President and CEO Eldron Blackwell - CFO Andrew Fentress - Chairman Kyle Brengel - VP, Operations Conference Call Participants Matthew Erdner - Jones Trading Chris Muller - Citizens Bank Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2024 ACRES Commercial Realty Corp. Earnings Conference Call. Currently, all participants are in a listen-only mode.
ACRES Commercial (ACR) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.55 per share a year ago.
Investing in real estate investment trusts (REITs) is an excellent option for long-term investors looking to create meaningful passive income streams in retirement.
ACRES Commercial Realty Corp. (NYSE:ACR ) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET Company Participants Kyle Brengel - VP of Operations Mark Fogel - President and CEO Eldron Blackwell - CFO Andrew Fentress - Chairman Conference Call Participants Matthew Erdner - Jones Trading Stephen Laws - Raymond James Chris Muller - Citizens JPM Operator Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 ACRES Commercial Realty Corp. Earnings Conference Call. Currently, all participants are in a listen-only mode.
ACRES Commercial (ACR) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.73 per share a year ago.
ACRES Commercial Realty is trading for 66 cents on the dollar. The mREIT continues to buy back shares and has $4.1 million outstanding on its buyback program. CECL reserve and the CRE loan portfolio risk rating were both up sequentially.
Acrivon Therapeutics shows promise in precision oncology with its AP3 platform and positive Phase 2 data for ACR-368, indicating potential for significant stock growth. Acrivon's robust pipeline, including the accelerated development of ACR-2316, and a strong cash position, highlight its commitment to advancing innovative cancer therapies. Despite being pre-revenue and operating at a loss due to high R&D expenses, ACRV maintains a healthy cash balance, crucial for ongoing operations and development.
ACRES Commercial Realty Corp. (NYSE:ACR ) Q2 2024 Earnings Call Transcript August 1, 2024 10:00 AM ET Company Participants Kyle Brengel - VP of Operations Mark Fogel - President and CEO Eldron Blackwell - CFO Andrew Fentress - Chairman Conference Call Participants Stephen Laws - Raymond James Chris Muller - Citizens JMP Operator Good day, ladies and gentlemen, and welcome to the Second Quarter 2024 ACRES Commercial Realty Corp. Earnings Conference Call. Currently, all participants are in a listen-only mode.
ACRES Commercial (ACR) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.60 per share a year ago.
Investors need to pay close attention to ACRES Commercial (ACR) stock based on the movements in the options market lately.